Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07288190
PHASE2

Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR

Sponsor: HIV Prevention Trials Network

View on ClinicalTrials.gov

Summary

To evaluate adherence to a single dual-prevention pill (DPP) compared with a two-pill regimen (2PR) for pre-exposure prophylaxis (PrEP) and pregnancy prevention in women without HIV.

Official title: A Multisite, Open-label, Randomized Crossover Study Comparing Adherence to a Single Daily Dual Prevention Pill (DPP) Versus FTC/TDF and Combined Oral Contraception Separate Pill Dosing (2PR), Given for Pre-exposure Prophylaxis and Pregnancy Prevention in Women

Key Details

Gender

FEMALE

Age Range

16 Years - 39 Years

Study Type

INTERVENTIONAL

Enrollment

300

Start Date

2026-05-15

Completion Date

2028-05-15

Last Updated

2026-02-19

Healthy Volunteers

Yes

Interventions

DRUG

DPP

Daily, single, co-formulated, FTC/TDF + combined ethinyl estradiol/levonorgestrel oral contraceptive pill

DRUG

2PR

Daily, two-pill regimen of oral FTC/TDF and ethinyl estradiol/levonorgestrel oral contraceptive pill

DRUG

Free Choice

Choice of either DPP or 2PR

Locations (3)

Eswatini Prevention Center CRS

Mbabane, Eswatini

MU-JHU Research Collaboration (MUJHU CARE LTD) CRS

Kampala, Uganda

Spilhaus CRS

Harare, Zimbabwe